Scientific Director of Bioanalytical at RoukenBio. Andrew has a PhD in Neurotoxicology from Newcastle University. He has been working in scientific roles in CROs for the past 12 years, focussed on delivering the highest standards of customer service and therapeutic characterisation using SPR and bioassays.
He has a particular interest in efficient bioassay design and development, qualification and troubleshooting of test methods for protein characterisation.
So, you’re confident that you’ve got a feasible assay with a well-defined dose-response curve. But bioassays, as we all know, are fickle. The observed responses are sensitive to many... read more →